IFNK

From WikiMD's WELLNESSPEDIA

(Redirected from Interferon kappa)

IFNK‏‎ (Interferon kappa) is a protein that in humans is encoded by the IFNK gene. It is a member of the interferon family, which are proteins released by host cells in response to the presence of pathogens such as viruses, bacteria, parasites, and also tumor cells.

Function[edit]

IFNK is a type I interferon and is produced in response to viral infection. It plays a crucial role in the immune response by inducing the expression of antiviral proteins and enhancing the presentation of antigens to immune cells. This helps to inhibit viral replication and stimulate the immune system to clear the infection.

Clinical significance[edit]

Alterations in the function or expression of IFNK can have significant clinical implications. For example, reduced levels of IFNK have been associated with increased susceptibility to viral infections. Conversely, overexpression of IFNK can lead to chronic inflammation and autoimmune diseases.

Research[edit]

Research into IFNK is ongoing, with studies investigating its role in various diseases and its potential as a therapeutic target. For example, IFNK has been implicated in the pathogenesis of diseases such as multiple sclerosis and lupus. In addition, there is interest in harnessing the antiviral and immune-stimulating properties of IFNK for the treatment of viral infections and cancer.

See also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.